Director of Cardiac Care Unit, Mount Sinai St Luke’s, Amsterdam Ave, New York, USA
Research Article
Concerns for the Use of Impella in Patients with Cardiogenic Shock
Complicating Acute Myocardial Infarction
Author(s): Abed R*, Bachoo N, Lucas CH, Nassar R and Herzog E
Introduction: To our knowledge, there has been no conclusive evidence so far to guide the choice between
impella and intra-aortic balloon pump (IABP) in patients with ischemic cardiogenic shock. Using the 2016 National
Inpatient Sample (NIS), this work aims to compare in-hospital outcomes among patients presenting with ischemic
cardiogenic shock treated without mechanical support, with impella, or with IABP.
Methods: Data was obtained from the 2016 NIS database. The primary outcome was in-patient mortality.
Secondary outcomes were hospital length of stay and total hospital charge. A series of univariate and multivariate
regression analyses were conducted on STATA 15.1.
Results: In this dataset, 11710 observations met the criteria of adults, acute ischemia and cardiogenic shock.
Among these, 7727.. Read More»
Cardiovascular Diseases & Diagnosis received 427 citations as per Google Scholar report